No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ETON250117P2500
- 0.00
- 0.000.00%
15min DelayClose Jan 13 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV82.14%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.52Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
B.Riley Financial Initiates Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $21
Investing in Eton Pharmaceuticals (NASDAQ:ETON) Three Years Ago Would Have Delivered You a 177% Gain
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $18
H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $17
Eton Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Citi Initiates Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $17